784 related articles for article (PubMed ID: 32479682)
1. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study.
Mendoza M; Garcia-Ruiz I; Maiz N; Rodo C; Garcia-Manau P; Serrano B; Lopez-Martinez RM; Balcells J; Fernandez-Hidalgo N; Carreras E; Suy A
BJOG; 2020 Oct; 127(11):1374-1380. PubMed ID: 32479682
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic profiling in HELLP syndrome cases with or without hypertension and proteinuria.
Trottmann F; Baumann M; Amylidi-Mohr S; Surbek D; Risch L; Mosimann B; Raio L
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():93-96. PubMed ID: 31678761
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Gómez-Montes E; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2013 May; 41(5):530-7. PubMed ID: 23303638
[TBL] [Abstract][Full Text] [Related]
4. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational study.
Serrano B; Bonacina E; Garcia-Ruiz I; Mendoza M; Garcia-Manau P; Garcia-Aguilar P; Gil J; Armengol-Alsina M; Fernández-Hidalgo N; Sulleiro E; Castillo-Ribelles L; Maiz N; Carreras E; Suy A
Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100760. PubMed ID: 36195282
[TBL] [Abstract][Full Text] [Related]
6. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia.
Binder J; Palmrich P; Kalafat E; Haberl C; Schirwani N; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):843-851. PubMed ID: 37265117
[TBL] [Abstract][Full Text] [Related]
8. Role of sFlt-1/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome.
Karge A; Beckert L; Moog P; Haller B; Ortiz JU; Lobmaier SM; Abel K; Flechsenhar S; Kuschel B; Graupner O
Pregnancy Hypertens; 2020 Oct; 22():160-166. PubMed ID: 32992124
[TBL] [Abstract][Full Text] [Related]
9. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
10. Contingent screening in stratification of pregnancy care based on risk of pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Bouariu A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):553-560. PubMed ID: 34309913
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia.
Lau K; Wright A; Sarno M; Kametas NA; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 May; 59(5):606-612. PubMed ID: 35132725
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
13. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
[TBL] [Abstract][Full Text] [Related]
14. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
15. Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management.
Nobrega GM; Guida JP; Novaes JM; Solda LM; Pietro L; Luz AG; Lajos GJ; Ribeiro-do-Valle CC; Souza RT; Cecatti JG; Mysorekar IU; Dias TZ; Laura Costa M
Pregnancy Hypertens; 2023 Mar; 31():32-37. PubMed ID: 36525933
[TBL] [Abstract][Full Text] [Related]
16. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
[TBL] [Abstract][Full Text] [Related]
17. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
18. Screening for pre-eclampsia at 35-37 weeks' gestation.
Panaitescu A; Ciobanu A; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):501-506. PubMed ID: 29896778
[TBL] [Abstract][Full Text] [Related]
19. Fetal cardiac function at 35-37 weeks' gestation in pregnancies that subsequently develop pre-eclampsia.
Semmler J; Garcia-Gonzalez C; Sanchez Sierra A; Gallardo Arozena M; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):417-422. PubMed ID: 33098138
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
Navaratnam K; Abreu P; Clarke H; Jorgensen A; Alfirevic A; Alfirevic Z
J Matern Fetal Neonatal Med; 2019 Jan; 32(2):179-187. PubMed ID: 28851242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
